Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •Abstract
- •1.1 Introduction
- •1.1.1 Historical Background
- •1.3.2 Pulmonary Drug Delivery
- •1.3.3 Parenteral Drug Delivery
- •1.4 Inulin Health Benefits
- •1.4.1 Prebiotic Effects
- •1.5 Inulin Industrial Applications
- •1.5.2 Pharmaceutical Uses
- •1.6.2 Regulatory Status Worldwide
- •1.7.1 Emerging Health Benefits
- •1.8 Conclusion
- •References
- •1.3 Inulin Drug Delivery Routes
- •1.3.1 Oral Drug Delivery
- •Abstract
- •2.1 Introduction
- •2.4 Physicochemical Characteristics
- •2.4.1 Chain Length
- •2.4.2 Solubility
- •2.4.3 Viscosity
- •2.4.4 Melting Temperature
- •2.4.5 Gelling
- •2.5.1 Extraction Through Hot Water
- •2.5.2 Extraction Using Ultrasound
- •2.5.3 Extraction Directed Through Microwave
- •2.7.1 Therapeutic Benefits
- •2.7.1.2 As Laxative
- •2.7.1.3 In Lipid Metabolism
- •2.7.1.5 Absorption Enhancer
- •2.8 Pharmaceutical Benefits
- •2.8.3 In PEGylation
- •2.8.5 As Gel
- •2.9 Diagnostic Benefits
- •2.10.2 Yield Variability
- •2.10.3 Purity Challenges
- •2.11 Future Scope
- •2.12 Conclusion
- •References
- •Abstract
- •3.1 Introduction
- •3.2 Inulin-Based Drug Formulations
- •3.3.1 Inulin-Based Hydrogels
- •3.3.2 Inulin-Based Micelles
- •3.3.3 Inulin-Based Liposomes
- •3.3.4 Inulin-Based Prodrugs
- •3.3.5 Inulin-Based Chelating Agents
- •3.3.6 Inulin-Based Microparticles
- •3.3.7 Inulin-Based Nanoparticles
- •3.6 Conclusions
- •References
- •Abstract
- •4.1 Introduction
- •4.3.1 Emulsifying Properties
- •4.3.3 Particle Stabilization
- •4.5.1 Solid Dosage Forms
- •4.5.3 Parenteral Formulations
- •4.5.4 Drug Delivery Systems
- •4.6.1 Skin Care Products
- •4.6.2 Hair Care Products
- •4.6.3 Personal Hygiene Products
- •4.7.2 Blood Sugar Regulation
- •4.9 Conclusion
- •References
- •Abstract
- •5.1 Introduction
- •5.5 Inulin-Based Drug Delivery Systems
- •5.5.1 Inulin Film Coating Agents
- •5.5.2 Biodegradable Inulin Coatings
- •5.5.3 Multipulse Delivery
- •5.5.4 Functional Inulin Coating Materials
- •5.5.5 Inulin Enteric Coatings/Colon Targeting
- •5.5.6 Tumor Targeting
- •5.5.7 Inulin Sustained Release Coatings
- •5.5.8 Hybrid Inulin-Based Coating Materials
- •5.5.9 Inulin Taste-Masking Coatings
- •5.5.10 Nanotechnology Using Inulin
- •5.7.1 Agriculture
- •5.7.2 Diagnosis
- •5.7.3 MRI Diagnosis
- •5.7.4 Medicine
- •5.7.5 Bioremediation
- •References
- •Abstract
- •Abbreviations
- •6.1 Introduction
- •6.1.1 Background
- •6.2 Understanding Prebiotics
- •6.4.2 Fermentation by Gut Microbiota
- •6.6.1 Bidirectional Communication
- •6.8 Future Perspective
- •6.9 Conclusion
- •References
- •7.2.2 Anti-Inflammatory Effects
- •7.3.1 Skin Whiteners
- •7.3.2 Hair Care
- •7.4 Regulatory Status
- •7.5 Conclusion
- •References
- •Abstract
- •7.1 Introduction
- •Abstract
- •8.1 Introduction
- •8.2.3 Anatomical Characteristics
- •8.2.4 Thermodynamic Stability
- •8.4.2 Formulation Strategies
- •8.5.3 Regulatory Considerations
- •8.9 Regulatory Considerations
- •8.11 Conclusion
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Inulin-Based Pharmaceutical Applications
- •9.3.1.1 GIT
- •9.3.1.2 CNS
- •9.3.1.3 CVS
- •9.3.1.4 Hypersensitivity Reactions
- •9.3.1.5 Other Reported Adverse Effects
- •9.3.2 Inulin Interactions
- •9.4.1 Acceptable Daily Intake
- •9.4.3.2 Adults
- •9.4.3.3 Elderly Individuals
- •9.4.3.4 Pregnant or Lactating Women
- •9.5.1 Clinical Trial Outcome
- •9.5.2 Animal Studies
- •9.5.3 In Vitro Studies
- •9.6 Future Prospects
- •9.7 Conclusion
- •References
- •Abstract
- •Abbreviations
- •10.1 Introduction
- •10.2.2.1 Prebiotic Activity
- •10.2.2.2 Improved Gut Health
- •10.2.2.3 Anti-Inflammatory Effects
- •10.2.2.5 Enhanced Mineral Absorption
- •10.6.1 Potential Side Effects
- •10.6.2 Dosage Recommendations
- •10.7 Future Perspective
- •10.8 Conclusion
- •References
- •Abstract
- •11.19.1 Tolerance
- •11.20 Conclusion
- •References
- •Abstract
- •12.1 Introduction
- •12.5.1 Hydrogels
- •12.5.2 Microparticles
- •12.5.3 Nanoparticles
- •12.5.4 Inulin Conjugates
- •12.5.5 Miscellaneous
- •12.7 Conclusion
- •References
- •Abstract
- •13.5.1 Pharmaceutical Quality Assurance Framework
- •References
- •Abstract
- •14.1 Introduction
- •14.2.1 Prebiotic Nature
- •14.8 Immune-Modulatory Effects
- •14.9.3 Addressing Bone-Related Disorders
- •14.12 Cognitive Implications
- •14.13 Future Directions
- •14.14 Conclusion
- •References
- •Abstract
- •15.1 Introduction
- •15.3 Extraction Techniques
- •15.7.1 In Pharmaceutical Sector
- •15.7.1.4 As Vaccine Adjuvant
- •15.7.2 In Food Sector
- •References
- •Abstract
- •16.1 Introduction
- •16.1.3 Innovative Drug Delivery Systems
- •16.2 Functional Properties
- •16.2.1 Liquidity
- •16.2.2 Prebiotic Characteristics
- •16.2.3 Low Energy Density
- •16.2.5 Potential Health Benefits
- •16.3.3 Mucosal Delivery Systems
- •16.3.4 Liposomes
- •16.5 Future Perspectives
- •References

177
Fig. 9.2 Maximum daily average recommended dose of inulin to various population
inulin may affect the absorption of several nutrients and minerals such as iron in
children and adolescents and may induce an imbalance in the nutrient level (Costa
et al. 2020). It can also cause digestive discomfort to some children, especially
when they initiate the consumption of inulin. Children with some health issues such
as inammatory bowel syndrome (IBS) may avoid the inulin intake, as it can worsen
the health condition (Salvatore etal. 2023). Therefore, it is important to monitor the
effect of inulin while initiating the inulin supplementation to the children. Inulin
might be effective in reducing body weight, increasing the fat-free muscle produc-
tion, and reducing obesity in children (Visuthranukul etal. 2022).
Constipation is one the common disorders in young age children, and inulin
supplementation can improve the condition by improving the consistency of stools;
however, some children may face the problem of loose stool after the consumption
of inulin (Closa-Monasterolo etal. 2017). A recent study by Visuthranukul etal. on
9 Toxicity andSafety Aspects ofInulin

178
effect of inulin supplementation to the obese child, found that inulin has the poten-
tial to increase the fat-free mass in these children (Visuthranukul etal. 2022).
9.4.3.2 Adults
Inulin has been reported safe for healthy adults at a high dose range, and even 40g
per day is safe; however, it may vary from person to person and the health condition
of the adults. Unhealthy, overweight, or obese adults or diabetic adults should
decrease the inulin intake and should not consume more than 20–25g per day as
mentioned in Table9.1 (Wijaya etal. 2022; Mitchell etal. 2021; Birkeland etal.
2020; Companys etal. 2022; Chambers etal. 2019).The patient undergoing perito-
neal dialysis also needs to take caution while consuming inulin and should not
increase the intake to more than 10g per day (Xiong etal. 2023).
9.4.3.3 Elderly Individuals
Inulin can induce some side effects in older people, and especially the people with
ulcerative colitis, inammatory bowel disease, or allergies require more caution
while using inulin to avoid any adverse events (Visuthranukul etal. 2022; Cai etal.
2018). Inulin helps to improve the gut microbiota in elderly people, and hence it is
consumed as probiotic, but few of them may experience the hypersensitive reactions
(Teferra 2021).
9.4.3.4 Pregnant or Lactating Women
There is limited research on the safety of inulin supplementation during pregnancy
and breastfeeding. As a precaution, pregnant or breastfeeding individuals should
consult their healthcare provider before using inulin supplements. Women suffering
from overweight or obesity or stress may also require caution in inulin consump-
tion. The gastrointestinal disorders such as atulence, soft stool, and nausea may be
produced at increased intake of inulin-based products (Vaghef-Mehrabani
etal. 2023).
9.5 Research Studies onInulin Safety
A number of preclinical and clinical studies have been done to identify the potential
effect, safety, and adverse effect of inulin. Various ndings have been reported on
the safety of inulin consumption or supplementation. Some clinical studies showed
that inulin consumption may increase the frequency of bowel movements with cer-
tain side effects (Liu etal. 2021).
9.5.1 Clinical Trial Outcome
There is limited data on clinical trials of drug formulations containing inulin.
However, several reports on the use of inulin microparticles, specically Advax as
vaccine adjuvant in different vaccines, indicate that delta inulin was well tolerated
S. K. Gupta and A. Verma

179
and safe (Petrovsky and Cooper 2015; Gordon etal. 2012). The use of these inulin
microparticles in vaccines tested in humans was found to be safe (Anjuomo
etal. 2021).
Guess etal. (2015) performed a randomized controlled trial on 44 subjects with
prediabetes condition. They were supplemented with inulin for 18weeks, and they
were found that inulin produced signicant body weight loss along with a reduction
in intrahepatocellular and intramyocellular lipid (Guess etal. 2015). Another ran-
domized controlled clinical trial on women with overweight and depressive condi-
tions, supplanted with inulin and kept on a calorie-restricted diet, reported that
women show some gastrointestinal complaints such as atulence, gastric discom-
fort, nausea, headache, etc. (Vaghef-Mehrabani etal. 2023). A recent study showed
that inulin supplementation induces muscle biomarkers and increases fat-free mass
(Visuthranukul etal. 2024).
A triple-blind, randomized controlled clinical trial on 49 type 2 diabetic women
was performed to assess the effect of inulin supplementation on blood sugar levels
and oxidative stress. The outcome of the study was that inulin does not produce any
signicant adverse signs in any of the women and showed blood glucose improve-
ment and antioxidant effect (Pourghassem Gargari etal. 2013). Several studies have
reported the side effects and toxic potential of inulin or inulin-based formulation
(Table9.2).
9.5.2 Animal Studies
Acute toxicity studies in animals have shown that inulin is generally well-tolerated,
with no signicant adverse effects observed at normal dietary levels. High doses of
inulin may cause gastrointestinal discomfort, including bloating and atulence, but
these effects are generally reversible (Tawck et al. 2022; Corrêa et al. 2023).
Subchronic and chronic studies in animals have been conducted to assess the safety
of prolonged exposure to inulin. These studies have generally shown a lack of sig-
nicant adverse effects. Inulin has been reported to be noncarcinogenic and non-
mutagenic (Carabin and Flamm 1999). Investigation of the toxicological prole of
inulin was studied by Johannsen (2003). Subacute oral toxicity of a duration of
weeks was performed on a group of rats with different doses of carboxymethylinu-
lin (CMI). The outcome of his ndings suggested that the CMI has no signicant
effect on body weight, food intake, hematological parameters, mortality, and lack of
toxic signs in any organ of the body at the highest dose. The motor activity was not
signicantly altered, and no sign of hypersensitive reactions or allergies has been
reported (Johannsen 2003). One more study was conducted in 9-week-old rats, to
investigate the inuence of dietary bers on microbiota composition, vitamin and
mineral absorption, and metabolic and immune indicators. The nding of this study
indicated that inulin supplementation has benecial effects on intestinal health and
may increase the absorption of minerals by promoting prebiotic activity (Massot-
Cladera etal. 2020). A high dose of inulin administration to the BALB/c mice,
showed an allergic response in ovalbumin (OVA)-sensitized mice, due to excessive
9 Toxicity andSafety Aspects ofInulin

180
Table 9.2 Side effects and safety considerations of some inulin-based formulation
S.
no
Formulation Effect Side effect
Safety
consideration MOA Dose Example Case studies
Reference
1 Inulin
injection
Glycemic
control, weight
management
Injection site
reaction,
hypoglycemia
Use with caution
in patients with
known allergies
to inulin or
related
compounds, and
monitor for sign
of allergies
reaction during
drug
administration
Modulates insulin
sensitivity and
glucose
metabolism and
acts as a plasma
volume expander,
increasing
intravascular
volume
Dosage
varies
based on
indication
and
patient’s
condition
Insuman
inulin
Patients with type
2 diabetes
experienced
improved
glycemic control
and weight loss
Wang
etal.
(2019)
2 Inulin
powder
Prebiotic
effects,
digestive health
Bloating,
atulence,
diarrhea
Start with low
doses and
increase
gradually to
minimize
gastrointestinal
discomfort, use
with caution for
gastrointestinal
disorder
Promotes helpful
gut bacteria,
enhances gut
health, acts as a
prebiotic
5–20g/
day
Beneo
Orafti
inulin
powder
Elderly
individuals
showed improved
bowel function
and reduced
constipation with
daily inulin
powder
supplementation
Watson
etal.
(2019)
3 Inulin
capsule
Weight
management,
gut health
Gastrointestinal
discomfort,
diarrhea
Take with plenty
of water; avoid in
individuals with
g.i.t. disorders,
start with low
doses and
increase
gradually
Promotes satiety,
decreases calorie
absorption, and
enhances the
composition and
function of the
gut microbiota
2–6g/day Inulex
lnulin
capsules,
ber
choice
inulin
capsules
The patient
experienced
reduced appetite
and improved
weight
management with
inulin capsule
supplementation
Jenko
Pražnikar
etal.
(2023)
S. K. Gupta and A. Verma

181
4 Inulin syrup Digestive
health, bowel
regularity
Nausea,
vomiting,
abdominal pain,
atulence
Use cautiously in
individuals with
fructose
intolerance or
sensitivity
Enhances bowel
motility, stool
consistency,
satises appetite,
and aids in
weight loss
10–30g/
day
Inulinex
syrup
Patients with
constipation
reported improved
bowel movements
and reduced
laxative use with
inulin syrup
Chang
etal.
(2023)
5 Inulin tablet Glycemic
control, lipid
metabolism
Stomach upset,
indigestion,
diarrhea, loose
stools
Monitor for
gastrointestinal
symptoms, avoid
in patient with
digestive disorder
and hydration
status, especially
in the elderly
Enhances insulin
sensitivity and
lipid prole by
modifying
glucose and lipid
metabolism
2–10g/
day
Inulin
plus
tablets
Diabetic patient
showed improved
blood sugar and
cholesterol level
with inulin tablet
supplementation
Paquette
etal.
(2023)
6 Inulin or
sinistrin
injection
As polymer in
food and
pharmaceutical
industries
Serious
hypersensitivity
reactions
The French
National Agency
for the Safety of
Medicines and
Health Products
(ANSM)
withdraw
products
containing inulin
and its analogue
Serious
hypersensitivity
reactions
– Injection Most adverse
reactions to inulin
and sinistrin are
hypersentivity
reactions
Bui etal.
(2021)
9 Toxicity andSafety Aspects ofInulin

182
accumulation of short-chain fatty acid (SCFA), and this study highlighted the per-
sonalized use of inulin-based products (Xie etal. 2023). Pauly etal. studied the
effect of short-term inulin-supplementation in the hepatic cholesterol and bile acid
metabolism in mice, and their ndings indicated that inulin can disturb the hepatic
metabolism and function (Pauly etal. 2020).
9.5.3 In Vitro Studies
Shang etal. performed invitro antioxidant activity of inulin by using DPPH radical
scavenging assays. The inulin-produced concentration dependency increased in
DPPH radical scavenging activities, but it was reported as a weak antioxidant
(Shang etal. 2018). Carabin and Flamm mentioned in their study that many invitro
studies reported that inulins do not have any mutagenic or genotoxic effects (Carabin
and Flamm 1999). Findings from both invivo and invitro research demonstrate that
consuming inulin-type fructans promotes the synthesis of SCFA (Moser etal. 2015).
One more invitro study was performed by Gunn etal. in 2022 and reported that
psyllium supplementation can reduce the gas production caused by the intake of
inulin, especially in individuals with inammatory bowel syndrome (IBS). They
used fecal samples from some patients with IBS and examined the invitro effect of
inulin and psyllium on the fermentation model (Gunn etal. 2022). A recent study on
the effect of inulin supplementation on obesity has been conducted. The ndings of
the invitro study indicated that the metabolites of Bidobacterium can utilize inulin
and decrease the level of cytokines and TNF-α, indicating its anti-inammatory
potential. Inulin promotes fat-free muscle production and decreases systemic
inammation (Visuthranukul etal. 2024). Much of the data is not available on
invitro studies of inulin related to its assessment of its safety and toxicity, and there-
fore there is a need for research to assess the safety and toxicity properties of inulin.
9.6 Future Prospects
The future prospects regarding the safety and toxicity of inulin appear to be promis-
ing. Inulin, a natural dietary ber found in many plants, is widely recognized for its
prebiotic properties and health benets. Studies have shown that inulin-type fruc-
tans, even when consumed at high levels, do not result in signicant adverse effects
such as mortality, morbidity, target organ toxicity, reproductive or developmental
toxicity, or carcinogenicity. In terms of safety, inulin is reported as safe for use in
foods by many legal authorities worldwide, and as a food ingredient, it can be used
without restriction in food formulation. However, at high doses, some individuals
may experience increased gastric discomfort due to osmotic pressure, and it may
vary from person to person. Inulin has a variety of applications in the pharmaceuti-
cal industry due to its unique and exible structure, which makes it an excellent
carrier for drug delivery.
S. K. Gupta and A. Verma

183
9.7 Conclusion
Inulin, a type of ber, has been widely used in human diets for centuries due to its
safety and gastrointestinal tolerance. However, recent studies have shown that high
intake of inulin can cause gastric distress, bloating, and changes in hepatic bile acid
metabolism. Inulin consumption can also cause cholestasis and negatively impact
liver function. Some individuals may experience digestive discomfort, irritable
bowel syndrome, and diarrhea due to its fermentable nature. Inulin can also increase
plasma cholesterol levels and exacerbate atherosclerosis. Some individuals may
experience allergic reactions, and it is important to seek medical attention if a reac-
tion is suspected. Inulin-type dietary supplementation should be person-specic to
ensure safe and effective health benets. It is generally safe for most people but may
cause adverse effects like bloating, constipation, cramps, back pain, and headache.
Therefore, toxicity and safety considerations are important while using or develop-
ing inulin-based pharmaceutical products.
Acknowledgments The authors are obliged to the Chairman and Group Director, Rungta College
of Pharmaceutical Sciences and Research, Bhilai, for providing support in every possible form. We
also acknowledge the Central Research Committee, SRGI, Bhilai, for providing the facility to pol-
ish the book chapter language.
ContributionsAll authors made signicant contribution in writing the manuscript, and all
authors have approved the nal version of the manuscript.
Declaration of Competing Interest The authors do not have any conict of interest to declare.
References
Anjuomo F, Barclay TG, Song Y, Parikh A, Petrovsky N, Garg S (2019) Synthesis and charac-
terization of a novel inulin hydrogel crosslinked with pyromellitic dianhydride. React Funct
Polym 134:104–111. https://doi.org/10.1016/j.reactfunctpolym.2018.10.014
Anjuomo F, Abdella S, Youssef SH, Song Y, Garg S (2021) Inulin and its application in drug
delivery. Pharmaceuticals 14(9):855. https://doi.org/10.3390/ph14090855
Akram W, Garud N, Joshi R (2019) Role of inulin as prebiotics on inammatory bowel disease.
Drug Discov Ther 13(1):1–8. https://doi.org/10.5582/ddt.2019.01000
Ali A, Saroj S, Saha S, Gupta SK, Rakshit T, Pal S (2023) Glucose-responsive chitosan nanopar-
ticle/poly(vinyl alcohol) hydrogels for sustained insulin release in vivo. ACS Appl Mater
Interfaces 15(27):32240–32250. https://doi.org/10.1021/acsami.3c05031
Ayala-Fuentes JC, Soleimani M, Magaña JJ, Gonzalez-Meljem JM, Chavez-Santoscoy RA (2023)
Novel hybrid inulin-soy protein nanoparticles simultaneously loaded with (−)-epicatechin
and quercetin and their in vitro evaluation. Nanomaterials (Basel) 13(10):2208. https://doi.
org/10.3390/nano13101615
Bărboi O-B, Chirilă I, Ciortescu I, Anton C, Drug V-L (2022) Inulin, choline and Silymarin in the
treatment of irritable bowel syndrome with constipation—randomized case-control study. J
Clin Med 11(8):2248. https://doi.org/10.3390/jcm11082248
Birkeland E etal (2020) Correction to: prebiotic effect of inulin-type fructans on faecal micro-
biota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial. Eur J Nutr
59(7):3339–3340. https://doi.org/10.1007/s00394- 020- 02314- 0
9 Toxicity andSafety Aspects ofInulin

184
Bonnema AL, Kolberg LW, Thomas W, Slavin JL (2010) Gastrointestinal tolerance of chicory
inulin products. J Am Diet Assoc 110(6):865–868. https://doi.org/10.1016/j.jada.2010.03.025
Bui T-V etal (2021) Safety of inulin and sinistrin: combining several sources for pharmacovigi-
lance purposes. Front Pharmacol 12:725417. https://doi.org/10.3389/fphar.2021.725417
Cadot P, Kochuyt A-M, van Ree R, Ceuppens JL (2003) Oral allergy syndrome to chicory
associated with birch pollen allergy. Int Arch Allergy Immunol 131(1):19–24. https://doi.
org/10.1159/000070430
Cai X etal (2018) Milk powder co-supplemented with inulin and resistant dextrin improves gly-
cemic control and insulin resistance in elderly type 2 diabetes mellitus: a 12-week random-
ized, double-blind, placebo-controlled trial. Mol Nutr Food Res 62(24):e1800865. https://doi.
org/10.1002/mnfr.201800865
Carabin IG, Flamm WG (1999) Evaluation of safety of inulin and oligofructose as dietary ber.
Regul Toxicol Pharmacol 30(3):268–282. https://doi.org/10.1006/rtph.1999.1349
Chambers ES etal (2019) Dietary supplementation with inulin-propionate ester or inulin improves
insulin sensitivity in adults with overweight and obesity with distinct effects on the gut micro-
biota, plasma metabolome and systemic inammatory responses: a randomised cross-over
trial. Gut 68(8):1430–1438. https://doi.org/10.1136/gutjnl- 2019- 318424
Chang L et al (2023) American Gastroenterological Association-American College of
Gastroenterology clinical practice guideline: pharmacological management of chronic
idiopathic constipation. Gastroenterology 164(7):1086–1106. https://doi.org/10.1053/j.
gastro.2023.03.214
Clark DE (1999) Rapid calculation of polar molecular surface area and its application to the predic-
tion of transport phenomena. 1. Prediction of intestinal absorption. J Pharm Sci 88(8):807–814.
https://doi.org/10.1021/js9804011
Closa-Monasterolo R etal (2017) The use of inulin-type fructans improves stool consistency in
constipated children. A randomised clinical trial: pilot study. Int J Food Sci Nutr 68(5):587–594.
https://doi.org/10.1080/09637486.2016.1263605
Companys J etal (2022) Effects of enriched seafood sticks (heat-inactivated B. animalis subsp.
lactis CECT 8145, inulin, omega-3) on cardiometabolic risk factors and gut microbiota in
abdominally obese subjects: randomized controlled trial. Eur J Nutr 61(7):3597–3611. https://
doi.org/10.1007/s00394- 022- 02904- 0
Corrêa RO et al (2023) Inulin diet uncovers complex diet-microbiota-immune cell inter-
actions remodeling the gut epithelium. Microbiome 11(1):90. https://doi.org/10.1186/
s40168- 023- 01520- 2
Costa G, Vasconcelos Q, Abreu G, Albuquerque A, Vilarejo J, Aragão G (2020) Changes in nutri-
ent absorption in children and adolescents caused by fructans, especially fructooligosaccha-
rides and inulin. Arch Pediatr 27(3):166–169. https://doi.org/10.1016/j.arcped.2020.01.004
Coussement PAA (1999) Inulin and oligofructose: safe intakes and legal status. J Nutr
129(7):1412S–1417S. https://doi.org/10.1093/jn/129.7.1412S
Dehghan P, Farhangi MA, Tavakoli F, Aliasgarzadeh A, Akbari AM (2016) Impact of prebiotic
supplementation on T-cell subsets and their related cytokines, anthropometric features and
blood pressure in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.
Complement Ther Med 24:96–102. https://doi.org/10.1016/j.ctim.2015.12.010
Di Prima G, Licciardi M, Bongiovì F, Pitarresi G, Giammona G (2021) Inulin-based polymeric
micelles functionalized with ocular permeation enhancers: improvement of dexametha-
sone permeation/penetration through bovine corneas. Pharmaceutics 13(9):1431. https://doi.
org/10.3390/pharmaceutics13091431
Du Y etal (2024) Protective effects of inulin on stress-recurrent inammatory bowel disease. Int J
Mol Sci 25(5):2494. https://doi.org/10.3390/ijms25052494
Ganie SA, Ali A, Mir TA, Mazumdar N (2022) Inulin–niacin conjugates: preparation, charac-
terization, kinetic and invitro release studies. J Polym Environ 30(2):504–515. https://doi.
org/10.1007/s10924- 021- 02210- 6
S. K. Gupta and A. Verma

185
Ghali ENHK, Pranav, Chauhan SC, Yallapu MM (2024) Inulin-based formulations as an emerg-
ing therapeutic strategy for cancer: a comprehensive review. Int J Biol Macromol 259:129216.
https://doi.org/10.1016/j.ijbiomac.2024.129216
Gontrani L etal (2024) Inulin-coated ZnO nanoparticles: a correlation between preparation and
properties for biostimulation purposes. Int J Mol Sci 25(5):2703. https://doi.org/10.3390/
ijms25052703
Gordon DL etal (2012) Randomized clinical trial of immunogenicity and safety of a recombinant
H1N1/2009 pandemic inuenza vaccine containing Advax™ polysaccharide adjuvant. Vaccine
30(36):5407–5416. https://doi.org/10.1016/j.vaccine.2012.06.009
Gruskiene R, Lavelli V, Sereikaite J (2024) Application of inulin for the formulation and delivery
of bioactive molecules and live cells. Carbohydr Polym 327:121670. https://doi.org/10.1016/j.
carbpol.2023.121670
Guess ND, Dornhorst A, Oliver N, Bell JD, Thomas EL, Frost GS (2015) A randomized controlled
trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes.
Nutr Metab (Lond) 12:36. https://doi.org/10.1186/s12986- 015- 0033- 2
Gunn D etal (2022) Psyllium reduces inulin-induced colonic gas production in IBS: MRI and
invitro fermentation studies. Gut 71(5):919–927. https://doi.org/10.1136/gutjnl- 2021- 324784
Hiel S etal (2018) Inulin improves postprandial hypertriglyceridemia by modulating gene expres-
sion in the small intestine. Nutrients 10(5):532. https://doi.org/10.3390/nu10050532
Hoving LR etal (2018) The prebiotic inulin aggravates accelerated atherosclerosis in hypercho-
lesterolemic APOE*3-leiden mice. Nutrients 10(2):172. https://doi.org/10.3390/nu10020172
Jenko Pražnikar Z, Mohorko N, Gmajner D, Kenig S, Petelin A (2023) Effects of four different
dietary bre supplements on weight loss and lipid and glucose serum proles during energy
restriction in patients with traits of metabolic syndrome: a comparative, randomized, placebo-
controlled study. Food Secur 12(11):2122. https://doi.org/10.3390/foods12112122
Johannsen FR (2003) Toxicological prole of carboxymethyl inulin. Food Chem Toxicol
41(1):49–59. https://doi.org/10.1016/S0278- 6915(02)00213- 2
Kalantari H, Asadmasjedi N, Abyaz MR, Mahdavinia M, Mohammadtaghvaei N (2019) Protective
effect of inulin on methotrexate- induced liver toxicity in mice. Biomed Pharmacother
110:943–950. https://doi.org/10.1016/j.biopha.2018.11.144
Kim S-H, Lee DH, Meyer D (2007) Supplementation of baby formula with native inulin has a
prebiotic effect in formula-fed babies. Asia Pac J Clin Nutr 16(1):172–177
Kishan CS, Akhila AR, Sahoo S, Kulkarni PK (2021) A comprehensive review on pharmaceutical
and nutritional applications of inulin. Int J Appl Pharm 13:30–38. https://doi.org/10.22159/
ijap.2021v13i3.40863
Li S etal (2021) Complexation of maltodextrin-based inulin and green tea polyphenols via dif-
ferent ultrasonic pretreatment. Ultrason Sonochem 74:105568. https://doi.org/10.1016/j.
ultsonch.2021.105568
Liang X, Lin D, Zhang W, Chen S, Ding H, Zhong H-J (2024) Progress in the preparation and
application of inulin-based hydrogels. Polymers (Basel) 16(11):1492. https://doi.org/10.3390/
polym16111492
Lin X, Zhang X, Xu B (2024) Differences in physicochemical, rheological, and prebiotic proper-
ties of inulin isolated from ve botanical sources and their potential applications. Food Res Int
180:114048. https://doi.org/10.1016/j.foodres.2024.114048
Liu X, Yang Q, He Z, Yao S (2021) Efcacy and safety of inulin supplementation for functional
constipation: a systematic review protocol. BMJ Open 11(4):e042597. https://doi.org/10.1136/
bmjopen- 2020- 042597
Massot-Cladera M, Azagra-Boronat I, Franch À, Castell M, Rodríguez-Lagunas MJ, Pérez-Cano
FJ (2020) Gut health-promoting benets of a dietary supplement of vitamins with inulin and
acacia bers in rats. Nutrients 12(8):2196. https://doi.org/10.3390/nu12082196
Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ (2015) Inulin, a exible
oligosaccharide. II: review of its pharmaceutical applications. Carbohydr Polym 134:418–428.
https://doi.org/10.1016/j.carbpol.2015.08.022
9 Toxicity andSafety Aspects ofInulin

186
Miles JP etal (2017) Supplementation of low- and high-fat diets with fermentable ber exacer-
bates severity of DSS-induced acute colitis. Inamm Bowel Dis 23(7):1133–1143. https://doi.
org/10.1097/MIB.0000000000001155
Mitchell CM et al (2021) Prebiotic inulin supplementation and peripheral insulin sensitivity
in adults at elevated risk for type 2 diabetes: a pilot randomized controlled trial. Nutrients
13(9):3235. https://doi.org/10.3390/nu13093235
Moser M, Sentko A, Alexiou H (2015) Inulin and health benets. In: Polysaccharides. Springer,
Cham, pp675–715. https://doi.org/10.1007/978- 3- 319- 16298- 0_37
Mysonhimer AR, Holscher HD (2022) Gastrointestinal effects and tolerance of nondigest-
ible carbohydrate consumption. Adv Nutr 13(6):2237–2276. https://doi.org/10.1093/
advances/nmac094
Oswari H etal (2019) Dosage-related prebiotic effects of inulin in formula-fed infants. Pediatr
Gastroenterol Hepatol Nutr 22(1):63–71. https://doi.org/10.5223/pghn.2019.22.1.63
Paquette S, Thomas SC, Venkataraman K, Appanna VD, Tharmalingam S (2023) The effects of
oral probiotics on type 2 diabetes mellitus (T2DM): a clinical trial systematic literature review.
Nutrients 15(21):4690. https://doi.org/10.3390/nu15214690
Pauly MJ etal (2020) Inulin supplementation disturbs hepatic cholesterol and bile acid metabo-
lism independent from housing temperature. Nutrients 12(10):3200. https://doi.org/10.3390/
nu12103200
Petrovsky N, Cooper PD (2015) Advax™, a novel microcrystalline polysaccharide particle engi-
neered from delta inulin, provides robust adjuvant potency together with tolerability and safety.
Vaccine 33(44):5920–5926. https://doi.org/10.1016/j.vaccine.2015.09.030
Pourghassem Gargari B, Dehghan P, Aliasgharzadeh A, Asghari Jafar-abadi M (2013) Effects of
high performance inulin supplementation on glycemic control and antioxidant status in women
with type 2 diabetes. Diabetes Metab J 37(2):140. https://doi.org/10.4093/dmj.2013.37.2.140
Rubin IMC et al (2022) Synbiotic intervention with lactobacilli, bidobacteria, and inulin in
healthy volunteers increases the abundance of bidobacteria but does not Alter microbial diver-
sity. Appl Environ Microbiol 88(19):e0108722. https://doi.org/10.1128/aem.01087- 22
Salvatore S, Battigaglia MS, Murone E, Dozio E, Pensabene L, Agosti M (2023) Dietary bers
in healthy children and in pediatric gastrointestinal disorders: a practical guide. Nutrients
15(9):2196. https://doi.org/10.3390/nu15092208
Sardo C etal (2022) Inulin-g-poly-D,L-lactide, a sustainable amphiphilic copolymer for nano-thera-
peutics. Drug Deliv Transl Res 12(8):1974–1990. https://doi.org/10.1007/s13346- 022- 01135- 4
Saud KT, Xu J, Wilkanowicz S, He Y, Moon JJ, Solomon MJ (2023) Electrosprayed microparticles
from inulin and poly(vinyl) alcohol for colon targeted delivery of prebiotics. Food Hydrocoll
140:108625. https://doi.org/10.1016/j.foodhyd.2023.108625
Setyaningsih D, Kurniawan EV, Hartini YS (2022) The potency of inulin to increase curcumin
aqueous solubility as a co-processing material with Curcuma longa in solid dispersion
approach. https://doi.org/10.2991/absr.k.220406.046
Shang H-M, Zhou H-Z, Yang J-Y, Li R, Song H, Wu H-X (2018) In vitro and invivo antioxidant
activities of inulin. PLoS One 13(2):e0192273. https://doi.org/10.1371/journal.pone.0192273
Shen J etal (2024) Oral curcumin–thioketal–inulin conjugate micelles against radiation–induced
enteritis. Antioxidants 13(4):417. https://doi.org/10.3390/antiox13040417
Sheng W, Ji G, Zhang L (2023) Immunomodulatory effects of inulin and its intestinal metabolites.
Front Immunol 14:1224092. https://doi.org/10.3389/mmu.2023.1224092
Shi F etal (2023) Preliminary exploration of inulin and inulin liposome on DSS-induced colitis
remission. J Drug Deliv Sci Technol 88:104911. https://doi.org/10.1016/j.jddst.2023.104911
Shoaib M etal (2016) Inulin: properties, health benets and food applications. Carbohydr Polym
147:444–454. https://doi.org/10.1016/j.carbpol.2016.04.020
Stribling P, Ibrahim F (2023) Dietary bre denition revisited- the case of low molecular weight
carbohydrates. Clin Nutr ESPEN 55:340–356. https://doi.org/10.1016/j.clnesp.2023.04.014
Talukdar JR et al (2024) The effects of inulin-type fructans on cardiovascular disease risk fac-
tors: systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr
119(2):496–510. https://doi.org/10.1016/j.ajcnut.2023.10.030
S. K. Gupta and A. Verma
Соседние файлы в папке Библиотека им академика М.И. Перельмана
